Sensus Healthcare Reports Q2 2026 Financial Results and Analyst Rating Update

Sensus Healthcare reported a significant revenue decline and an adjusted net loss in Q2 2026. Unit sales fell to 11 after eight funded units were delayed; the units have since been approved and are expected to be recognized in Q3. Lake Street maintained its Buy rating on SRTS but lowered its price target from $4.50 to $4.00.